Sever Pharma Solutions acquires Foster Delivery Science, Inc.

Malmö, Sweden, November 5, 2021 — Sever Pharma Solutions (SPS), today announced it has entered into a definitive agreement to acquire the assets of Foster Delivery Science (FDS) located in Putnam, Connecticut.

The acquisition of FDS, which is expected to be completed in November, will significantly expand SPS’s ability to leverage its expertise in the development of high-potent pharmaceutical products.

https://www.severpharmasolutions.com/wp-content/uploads/2021/11/20211109-Press-Release-SPS_Foster-FINAL.pdf

Launch of Annovera in US

NEW R&D DIRECTOR

Dapivirine IVR receives positive opinion from EMA

New VP operations

New Group CFO